Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016)
Jazz Pharmaceuticals (JAZZ) posted quarterly Construction in Progress of $66.2 million for Q1 2016, up 33.85% year-over-year from $49.4 million in Q2 2015, and up 5.04% quarter-over-quarter from $63.0 million in Q4 2015.
Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Construction in Progress history runs 7 years deep, the most recent figure standing at $66.2 million for Q1 2016.
- In Q1 2016, Construction in Progress rose 33.85% year-over-year to $66.2 million; the TTM figure through Mar 2016 stood at $66.2 million (up 33.85% YoY), while the FY2015 annual figure was $63.0 million, up 69.63% from the prior year.
- Construction in Progress for Q1 2016 stood at $66.2 million, up from $63.0 million in the prior quarter.
- The five-year high for Construction in Progress was $66.2 million in Q1 2016, with the low at $148000.0 in Q1 2012.
- The 5-year median for Construction in Progress is $10.6 million (2014), against an average of $24.0 million.
- The sharpest annual moves came in 2013 and 2016: Construction in Progress soared 1239.19% in 2013, then soared 33.85% in 2016.
- Jazz Pharmaceuticals' Construction in Progress stood at $1.1 million in 2012, then jumped by 286.61% to $4.4 million in 2013, then jumped by 746.51% to $37.1 million in 2014, then soared by 69.63% to $63.0 million in 2015, then rose by 5.04% to $66.2 million in 2016.
- Business Quant data shows JAZZ's Construction in Progress at $66.2 million in Q1 2016, $63.0 million in Q4 2015, and $61.1 million in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 152.67 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 66.19 Mn |
| Dec 31, 2015 | 63.01 Mn |
| Sep 30, 2015 | 61.06 Mn |
| Jun 30, 2015 | 57.88 Mn |
| Mar 31, 2015 | 49.45 Mn |
| Dec 31, 2014 | 37.15 Mn |
| Sep 30, 2014 | 24.25 Mn |
| Jun 30, 2014 | 18.04 Mn |
| Mar 31, 2014 | 10.64 Mn |
| Dec 31, 2013 | 4.39 Mn |
| Sep 30, 2013 | 5.06 Mn |
| Jun 30, 2013 | 4.20 Mn |
| Mar 31, 2013 | 1.98 Mn |
| Dec 31, 2012 | 1.14 Mn |
| Sep 30, 2012 | 1.05 Mn |
| Jun 30, 2012 | 2.46 Mn |
| Mar 31, 2012 | 148,000.00 |
| Dec 31, 2011 | 689,000.00 |
| Dec 31, 2010 | 73,000.00 |